Innate (non-specific) immunity:
Present from birth
Immediate response
Includes physical and chemical barriers (e.g., skin, stomach acid)
Phagocytes (neutrophils and macrophages)
Inflammation and fever
Adaptive (specific) immunity:
Slower initial response
Specific to particular pathogens
Has memory (quicker upon re-exposure)
Phagocytes:
Engulf and digest pathogens (phagocytosis)
Present antigens on surface (antigen-presenting cells or APCs)
Lymphocytes:
B lymphocytes (B cells):
Mature in bone marrow
Produce antibodies
Involved in humoral immunity
T lymphocytes (T cells):
Mature in thymus
Recognize antigens presented by APCs
Involved in cell-mediated immunity
T helper cells (CD4+):
Activate B cells and cytotoxic T cells
Secrete cytokines
Cytotoxic T cells (CD8+):
Destroy virus-infected or cancerous cells
Memory T cells:
Provide long-term immunity
Recognition of antigen by B or T cells
Clonal selection: Specific lymphocytes activated
Clonal expansion: Mitosis to produce identical cells
Differentiation into:
Plasma cells (B cells)
Memory cells
Effector T cells
Immunoglobulins (Ig): Proteins produced by plasma cells
Basic structure:
2 heavy chains, 2 light chains
Variable region (antigen-binding site) โ specific to antigen
Constant region โ determines antibody class and function
Hinge region โ provides flexibility
Neutralization: Bind to toxins or viruses to prevent harm
Agglutination: Clump pathogens for easier phagocytosis
Opsonization: Mark pathogens for destruction
Complement activation: Lysis of pathogens
IgG, IgA, IgM, IgE, IgD โ each with different roles (IgG most common)
A vaccine contains antigens that stimulate the immune system to produce memory cells without causing disease.
Live attenuated (weakened form of the pathogen)
Inactivated (killed pathogen)
Toxoid (inactivated toxins)
Subunit or recombinant (specific proteins or fragments)
Introduce antigen โ immune response โ memory B and T cells
On exposure to real pathogen:
Rapid production of antibodies
Faster, stronger immune response (secondary response)
Occurs when a large proportion of the population is vaccinated
Reduces spread, protecting unvaccinated individuals
Mass immunization schedules (e.g., MMR, polio, COVID-19)
Importance in global disease control (e.g., eradication of smallpox)
Antigenic variation (e.g., influenza virus)
Public misinformation or hesitancy
Need for boosters in some cases
Cold chain requirements (for storage/transport)
Feature | Primary Response | Secondary Response |
---|---|---|
Time to respond | Slower (days) | Faster (hours) |
Antibody levels | Lower peak | Higher peak |
Memory cells involved? | No | Yes |
Symptoms? | Often | Rarely |